NCT04354311

Brief Summary

The objective : to investigate a correlation between ANI following a standardized nociceptive stimulus and hemodynamic or somatic reactions during orotracheal intubation. Piloted study. ANI and hemodynamic and somatic parameters response associated tetanus stimulation followed by orotracheal intubation were collected.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 2, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
5.4 years until next milestone

First Submitted

Initial submission to the registry

April 14, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 21, 2020

Completed
Last Updated

December 22, 2025

Status Verified

April 1, 2020

Enrollment Period

10 months

First QC Date

April 14, 2020

Last Update Submit

December 15, 2025

Conditions

Keywords

ANIhemodynamic responsestracheal intubation

Outcome Measures

Primary Outcomes (1)

  • predictability of hemodynamic impact during laryngoscopy by tetanus-induced ANI variation,

    area under the corresponding Receiver Operating Characteristic curve with DeltaTetanus as dependent variable, and Hemodynamic Impact as state variable

    measurement during intubation, an average 40 seconds and 5 minutes

Secondary Outcomes (1)

  • predictability of somatic impact during laryngoscopy by tetanus-induced ANI variation,

    observation during intubation, an average between 40 seconds and 5 minutes

Study Arms (1)

Experimental

EXPERIMENTAL

Anesthetic induction : total target-controlled intravenous anesthesia d was used with propofol and remifentanil. The effect site was then gradually increased to obtain a satisfaction depth of anesthesia. Assisted ventilation was then started by facemask ventilation (Sat O2\>95% and expired CO2 fraction normal, tidal volume of 8 mL/kg, a respiratory rate of 12 cycles per minute, with an FiO2 100% with no positive end expiratory pressure. After stabilisation period of 2 minutes and record of the patient's parameters, a standardized nociceptive stimulation was applied at the level of the ulnar nerve (PTC of 50 Hz at 70 mA). The variation of ANI score and hemodynamic parameters were collected during the 2 following minutes. After stabilization of ANI, orotracheal intubation was attempted. Maximal variation of heart rate (HR), blood pressure and the occurrence of somatic manifestations (intense cough, movement, tears) were recorded.

Device: ANI

Interventions

ANIDEVICE

Under steady state total intravenous anaesthesia with propofol and remifentanil at constant dosage, tetanus stimulation of the ulnar nerve was performed followed by orotracheal intubation. The variation of ANI and hemodynamic parameters as well as the somatic response associated with both maneuvers were collected.

Experimental

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any patient requiring general anaesthesia with tracheal intubation by direct laryngoscopy
  • Intubation Difficulty Assessment Score \< 7
  • BMI between 17 and 30 Kg/m2
  • Socially insured patient
  • Patient 18 years of age or older
  • Patient with signed consent
  • Patient with a sinus heart rhythm

You may not qualify if:

  • Patient refusing to participate in the study
  • Pregnant woman
  • Patient with a pace maker (any mode)
  • Patient treated with Beta Blocker
  • Known Dysautonomia
  • Diabetes
  • Spontaneous ventilation anaesthesia
  • Allergy to any of the required medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Roger Salengro, CHU Lille

Lille, 59037, France

Location

Related Publications (1)

  • Jozefowicz E, Sabourdin N, Fontaine V, Lambelin V, Lejeune V, Menu H, Bourai M, Tavernier B. Prediction of reactivity during tracheal intubation by pre-laryngoscopy tetanus-induced ANI variation. J Clin Monit Comput. 2022 Feb;36(1):93-101. doi: 10.1007/s10877-020-00624-6. Epub 2021 Jan 2.

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Elsa Jozefowicz, MD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Patients under general anesthesia during the procedure
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Prospective, interventional, analytical, monocentric, piloted study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 14, 2020

First Posted

April 21, 2020

Study Start

February 2, 2014

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

December 22, 2025

Record last verified: 2020-04

Locations